Mid cap electronic manufacturing services (EMS) stock Flextronics International Ltd (NASDAQ: FLEX) reported Q1 2017 earnings after the market closed on Thursday with results missing Wall Street expectations and shares falling in afterhours/premarket trading. Net sales grew 2% to $6.0 billion and GAAP net income was approximately $125 millionversus net income of $106 million. The CEO commented:
“Our Sketch-to-Scale strategy remains firmly on track as reflected in our first quarter results which were within guidance ranges. While fiscal 2018 is an investment year, we continue to evolve our portfolio and enter and create new markets that will generate meaningful value and expand the Company’s total available market.”
A technical chart for Flextronics International shows shares mostly staying above a $16 support level:
Top Value Stocks To Own Right Now: Inogen, Inc(INGN)
- [By Michael A. Robinson]
I put these rules in action for you in March 2015 when I recommendedInogen Inc.(Nasdaq: INGN)here in these pages.
Inogen is pioneering the use of portable oxygen concentrators (POCs). And theGoleta, Calif.-based firm boasts breakthrough technology that has disrupted its entire sector.
Top Value Stocks To Own Right Now: Newcastle Investment Corporation(NCT)
- [By Jim Robertson]
Today, our Under the Radar Moversnewsletter suggested shortingsmall cap debt and golf course REITNewcastle Investment Corp (NYSE: NCT):
this isn’t apt to become a huge winner, but it’s a high-odds winner.
- [By Lee Jackson]
Newcastle Investment Corp. (NYSE: NCT) also had a director buying shares this past week. Wesley Edens picked up1 million shares of the stock at a price of $4.37. The total for the trade was posted at $4,370,000. The consensus price target for the stock is $4.50.The company invests in and manages real estate related and other investments. Its stock ended the weekat $4.31.
Top Value Stocks To Own Right Now: (SHF)
- [By Money Morning Staff Reports]
In March 2012, Schiff Nutrition International Inc. (NYSE: SHF) acquired the company for $150 million in cash.
The product is still on the market today, found at most local drug stores. It is advertised now, however, as a nutritional supplement that does not, if taken alone, ward off viruses.